Barry E. Greene

2009 - Alnylam Pharmaceuticals

In 2009, Barry E. Greene earned a total compensation of $1M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 36% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$38,610
Option Awards$572,299
Salary$390,000
Other$5,992
Total$1,006,901

Greene received $572.3K in option awards, accounting for 57% of the total pay in 2009.

Greene also received $38.6K in non-equity incentive plan, $390K in salary and $6K in other compensation.

Rankings

In 2009, Barry E. Greene's compensation ranked 4,445th out of 9,885 executives tracked by ExecPay. In other words, Greene earned more than 55.0% of executives.

ClassificationRankingPercentile
All
4,445
out of 9,885
55th
Division
Manufacturing
1,582
out of 3,690
57th
Major group
Chemicals And Allied Products
308
out of 866
64th
Industry group
Drugs
186
out of 638
71st
Industry
Pharmaceutical Preparations
147
out of 446
67th
Source: SEC filing on May 2, 2011.

Greene's colleagues

We found four more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2009.

2009

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2009

Akshay Vaishnaw

Alnylam Pharmaceuticals

Senior Vice President, Clinical Research

2009

John Schmidt

Alnylam Pharmaceuticals

Chief Scientific Officer

2009

Patricia Allen

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer

News

In-depth

You may also like